Dr. Prigerson and her team will be piloting several interventions targeted to end-stage cancer patients and their caregivers to promote better communication and informed decision-making about care options.
As reported in Cell, these pain-sensing neurons protect against inflammation in the gut as well as the associated tissue damage, apparently by secreting a molecule called substance P.
The breakthrough research holds promise for developing diagnostic tests for the prediction of cancer progression and therapy.
IPF, which causes progressive scarring of the lungs due to chronic lung inflammation, is usually fatal because it tends to be diagnosed late in the process when treatments are less effective.
This award is the largest federal grant ever given to Weill Cornell Medicine and represents 20 years of continuous funding for the CTSC under Dr. Imperato-McGinley’s direction.
Building upon his laboratory’s many discoveries centered around ILC3s, Dr. Gregory Sonnenberg has published another breakthrough in Nature (September 7, 2022).
Dr. Jedd Wolchok has been appointed as the Meyer Director of the Sandra and Edward Meyer Cancer Center and Dr. Taha Merghoub as Deputy Director.
The Tri-institutional TB Research Advancement Center (TRAC) is a collaboration between an exceptional group of investigators at Weill Cornell Medicine, Cornell University, Rockefeller University, and Memorial Sloan Kettering Cancer Center.
This five-year, $1.25 million grant will enable Dr. Iliev to continue his innovative research into the relationship between certain types of fungi and specific cancers.
This award recognizes exceptional researchers whose scientific excellence and pioneering work have significantly advanced scientific development for the benefit of humanity.
